Precigen Inc (NASDAQ: PGEN) on Monday, soared 5.83% from the previous trading day, before settling in for the closing price of $1.20. Within the past 52 weeks, PGEN’s price has moved between $0.65 and $1.93.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -15.17%. The company achieved an average annual earnings per share of -20.51%. With a float of $163.53 million, this company’s outstanding shares have now reached $292.87 million.
Let’s determine the extent of company efficiency that accounts for 202 employees. In terms of profitability, gross margin is -63.15%, operating margin of -3277.95%, and the pretax margin is -3573.1%.
Precigen Inc (PGEN) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Precigen Inc is 44.16%, while institutional ownership is 26.04%. The most recent insider transaction that took place on Aug 09 ’24, was worth 50,000. In this transaction SVP, IP Affairs of this company bought 58,823 shares at a rate of $0.85, taking the stock ownership to the 743,097 shares. Before that another transaction happened on Aug 09 ’24, when Company’s Director bought 23,529,411 for $0.85, making the entire transaction worth $19,999,999. This insider now owns 64,547,214 shares in total.
Precigen Inc (PGEN) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -20.51% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 2.40% during the next five years compared to 36.94% growth over the previous five years of trading.
Precigen Inc (NASDAQ: PGEN) Trading Performance Indicators
Precigen Inc (PGEN) is currently performing well based on its current performance indicators. A quick ratio of 1.63 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 104.36.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.55, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.21 in one year’s time.
Technical Analysis of Precigen Inc (PGEN)
Looking closely at Precigen Inc (NASDAQ: PGEN), its last 5-days average volume was 4.82 million, which is a jump from its year-to-date volume of 4.42 million. As of the previous 9 days, the stock’s Stochastic %D was 72.59%. Additionally, its Average True Range was 0.12.
During the past 100 days, Precigen Inc’s (PGEN) raw stochastic average was set at 78.45%, which indicates a significant increase from 78.45% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 127.37% in the past 14 days, which was higher than the 80.52% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8553, while its 200-day Moving Average is $1.1948. However, in the short run, Precigen Inc’s stock first resistance to watch stands at $1.4167. Second resistance stands at $1.5633. The third major resistance level sits at $1.6867. If the price goes on to break the first support level at $1.1467, it is likely to go to the next support level at $1.0233. Should the price break the second support level, the third support level stands at $0.8767.
Precigen Inc (NASDAQ: PGEN) Key Stats
Market capitalization of the company is 413.27 million based on 292,869K outstanding shares. Right now, sales total 6,230 K and income totals -95,900 K. The company made 950 K in profit during its latest quarter, and -23,980 K in sales during its previous quarter.
